Registration Study for the Prevention and Treatment of Cerebral Hemorrhage using Naoxueshu Oral Liquid: Protocol for a Research Study

: Naoxueshu oral liquid is the only approved drug for acute treatment of cerebral hemorrhage in China. It has been used widely for the treatment of acute ischemic stroke and acute hemorrhagic stroke. However, safety and efficacy data on the early use of Naoxueshu oral liquid are lacking. The main purpose of this study is to observe the benefit and safety of early use of Naoxueshu oral liquid (
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research